DMD Advocates advised HBM Healthcare Investments on leading a ₹850 crore pre-listing fundraising round for OneSource Specialty Pharma Limited.
DMD Advocates' transaction team was led by Ayesha Rai (Partner) along with Pooja Shah (Principal Associate) and Vanshikha Choraria (Associate).
Vihang Virkar (Lead Partner) acted as the engagement partner on this assignment.
The capital raised will support Onesource’s growth, advance its research and development, and enhance its product offerings, which will strengthen the company’s market position ahead of its IPO.
OneSource Specialty Pharma is an Indian pharmaceutical company focused on developing and manufacturing complex medicines, including biologics, complex injectables, and soft gelatin capsules. They also serve as a Contract Development and Manufacturing Organization (CDMO), assisting other pharmaceutical companies in developing and producing their drugs.
HBM Healthcare Investments is a global investment firm specializing in the healthcare sector. Based in Zug, Switzerland, the company focuses on identifying and supporting innovative healthcare businesses worldwide, ranging from biotechnology and pharmaceuticals to medical devices and healthcare services.
HBM Healthcare Investments leverages its extensive industry expertise to provide strategic funding and guidance, enabling its portfolio companies to accelerate growth and innovation.
If you would like your Deals, Columns, Press Releases to be published on Bar & Bench, please fill in the form available here.